Nucorion Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
Phase 1
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Nucorion Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04629976
- Locations
- 🇺🇸
National Institute of Clinical Research, Inc, Monterey Park, California, United States
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Nucorion Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04309526
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
News
No news found